Literature DB >> 8960502

Intracoronary irradiation: dose response for the prevention of restenosis in swine.

J Weinberger1, H Amols, R D Ennis, A Schwartz, J G Wiedermann, C Marboe.   

Abstract

PURPOSE: Restenosis after percutaneous transluminal coronary angioplasty represents, in part, a proliferative response of vascular smooth muscle at the site of injury. We have previously shown that high-dose radiation (20 Gy), delivered via an intracoronary 192Ir source, causes focal medial fibrosis and markedly impairs the restenosis process after balloon angioplasty in swine. This study sought to delineate the dose-response characteristics of this effect. METHODS AND MATERIALS: Forty juvenile swine underwent coronary angiography; a segment of the left coronary artery was chosen as a target for balloon injury. In 30 swine, a 2 cm ribbon of 192Ir was positioned at the target segment and 20, 15, or 10 Gy were delivered to the vessel wall (10 animals/dose). Subsequently, overdilatation balloon angioplasty was performed at the irradiated segment. In 10 control swine, overdilatation balloon angioplasty was performed without previous irradiation. Thirty-eight animals survived until sacrifice at 30 +/- 3 days. Histopathological analysis was performed by a pathologist in a blinded manner. The area of maximal luminal compromise within the target segment was analyzed via computer-assisted planimetry.
RESULTS: Neointimal area was decreased by 71.4% at 20 Gy and by 58.3% at 15 Gy compared with control animals (p < 0.05 for both). A stimulatory effect on smooth muscle cell proliferation was noted at 10 Gy, with a 123% increase in neointimal area compared with controls (p < 0.05). Mean percent area stenosis was also reduced by 63% at 20 Gy and by 74.8% at 15 Gy compared with controls (p < 0.05 for both).
CONCLUSIONS: Intracoronary irradiation prior to overstretch balloon angioplasty markedly reduces neointima formation; this effect is dose dependent, with evidence of a significant stimulatory effect at 10 Gy. The effective therapeutic dose range for the prevention of restenosis in this model begins at approximately 15 Gy delivered to the vessel wall.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960502     DOI: 10.1016/s0360-3016(96)00294-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal.

Authors:  O F Bertrand; S Lehnert; R Mongrain; M G Bourassa
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

2.  Histopathology of coronary in-stent restenosis following gamma brachytherapy.

Authors:  H C Lowe; M Mino; E J Mark; B D Mac Neill; I F Palacios; S L Houser
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

3.  Intracoronary brachytherapy for in-stent restenosis: will it remain a viable therapy?

Authors:  Seong-Wook Park; Myeong-Ki Hong; Seung Jun Oh; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-16       Impact factor: 9.236

4.  Intracoronary radiation using radioisotope solution-filled balloons.

Authors:  J Weinberger
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

Review 5.  Endovascular brachytherapy--treatment planning and radiation protection.

Authors:  U Quast; D Flühs; M Bambynek
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

Review 6.  [Intravascular irradiation in the combined therapy and prevention of restenosis. Overview].

Authors:  D Baumgart; U Quast; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

7.  Effect of transcatheter endovascular radiation with holmium-166 on neointimal formation after balloon injury in porcine coronary artery.

Authors:  H S Kim; Y H Cho; J S Kim; Y T Oh; H J Kang; M S Chun; C W Joh; C H Park; K B Park; S J Tahk; B W Choi
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

8.  From basic biology to randomized clinical trial: the Beta Radiation for Arteriovenous Graft Outflow Stenosis (BRAVO II).

Authors:  Prabir Roy-Chaudhury; Perry Arnold; Jeff Seigel; Sanjay Misra
Journal:  Semin Dial       Date:  2012-10-16       Impact factor: 3.455

Review 9.  Intravascular brachytherapy for peripheral vascular disease.

Authors:  Alina Andras; Monica Hansrani; Marlene Stewart; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2014-01-08

10.  Wire or coated balloon? Searching for an optimal source for intravascular brachytherapy with beta emitters using (32)P as an example.

Authors:  J Lehmann; C R King
Journal:  J Appl Clin Med Phys       Date:  2003       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.